RIBOCOLORSTAR
LIVE

Serial Number

99888096

Owner

Suzhou Ribo Life Science Co., Ltd.

Attorney

Zhi Dong

Filing Date

Jun 16, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RIBOCOLORSTAR Trademark

Serial Number: 99888096

RIBOCOLORSTAR is a trademark filed by Suzhou Ribo Life Science Co., Ltd. on June 16, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Suzhou Ribo Life Science Co., Ltd. (12 trademarks)

168 Yuanfeng Road,

Entity Type: 16

Trademark Details

Filing Date

June 16, 2026

Registration Date

Not Registered

Goods & Services

technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; Development services of drugs; pharmaceutical product evaluation; Research and development services of new pharmaceutical products; Research and development in the field of pharmaceuticals; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemical research and analysis; Development of pharmaceutical preparations and medicines; Scientific research in the nature of conducting clinical trials for others; medical research; testing of pharmaceuticals; industrial design

Medicines for humans for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders, nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; crude drugs being pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders, nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders , nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemico-pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders , nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; Biological preparations for use in cell cultures for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders, nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, renal diseases, liver diseases, genetic disorders, nervous system diseases and rare ocular, respiratory, gastrointestinal, cerebral disease; diagnostic preparations for medical purposes; Phosphates for pharmaceutical purposes; sodium salts for medical purposes; Pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the peripheral nervous system; antidepressants; antiepileptic pharmaceutical preparations; pain relief medication; balsamic preparations for medical purposes; pharmaceutical preparations for the treatment of infectious diseases; pharmaceuticals for the treatment of viral diseases; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; Anticoagulants; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; pharmaceuticals for ophthalmological use; nucleic acid sequences for medical and veterinary purposes; dietetic foods and beverages adapted for medical use; depuratives for the body; pesticides; Medical dressings; Composite materials for dental and dental technical purposes; cardiovascular agents for medical purposes; anti-diabetic preparations; Pharmaceutical agents affecting peripheral nervous system; analgesics; Analgesic preparation; Antivirals; pharmaceutical preparations for the treatment of viral diseases; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; Anti-cancer preparations; biological preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; antihypertensives; hypolipidemic agents; Cholesterol reducers; ophthalmological preparations; diapers for pets

Filing History

APPLICATION FILING RECEIPT MAILED
Jun 16, 2026 MAFR
NEW APPLICATION ENTERED
Jun 16, 2026 NWAP